Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 17 October 2011 The MHRA and CHM have published the October edition of Drug Safety Update. This edition details […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 6 June 2011 Two recent observational studies (one in Canada and another in Sweden) have reported an increased risk of atypical femoral fractures in older women taking bisphosphonates, which […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 31 May 2011 Re-analysis of data from a large randomised controlled trial has found a modest increase in the risk of some cardiovascular events in postmenopausal women using calcium […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 16 November 2010 NICE recommends denosumab▼ (Prolia®) as a treatment option for the primary and secondary prevention of osteoporotic fragility fractures in postmenopausal women. However, it should only be […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 July 2010 Denosumab▼ subcutaneous injection (Prolia®), administered as a 60mg dose every six months, has been marketed in the UK for the treatment of osteoporosis in postmenopausal women at […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 15 April 2010 In the PEARL study of 8,556 women with postmenopausal osteoporosis, lasofoxifene 0.5mg daily reduced the risk of radiographic vertebral fractures after three years. At the end of […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 09 April 2010 The MHRA and CHM have published the April edition of Drug Safety Update Highlights include: Updated […]
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 23 February 2010 A meta-analysis found that daily calcium and vitamin D supplementation significantly reduced the overall risk of fracture across a wide age range of people, irrespective of […]